Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...
Cedars-Sinai researchers created “young” immune cells from human stem cells that reversed cognitive decline and Alzheimer’s ...
Ahead of Solano County's Walk to End Alzheimer's Saturday morning in Fairfield, one Rio Vista man reflects on how the meaning ...
A cup of coffee or green tea can do more than refresh you. Know which one boosts brain power, improves focus and may help ...
Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; ...
Midland Reporter-Telegram on MSN
3 can't-miss Midland events this week: walk, concert, gala
From the Walk to End Alzheimer’s to a chamber concert and the Howl-O-Ween Gala, here are Midland’s top events to plan your ...
Three Independent Studies Published in “Alzheimer’s Research & Therapy,” “Journal of Alzheimer’s Disease,” and “Radiology” ...
Dr Amir Khan has shared a snippet of the latest episode of his podcast, No Appointment Necessary, in which he and co-host ...
Labcorp announced it will begin offering the Elecsys pTau181 blood test nationwide by early 2026, making available the only FDA-cleared blood test in the U.S. to aid in the initial assessment for ...
In the latest Grey’s Anatomy season 22 teaser, Jesse Williams made a rare return as Dr. Jackson Avery, following his 2021 ...
Researchers found that even a short stretch of eating high-fat meals can disrupt key circuits tied to memory. The good news?
This represents Alector's second failed neurodegenerative asset in a year, after an AbbVie-partnered asset missed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback